In its second-quarter update, Shell announced that it would incur an impairment charge of up to $2 billion following the sale of its Singapore refinery and the halting of construction on one of Europe’s largest biofuel plants.
An impairment charge is a financial loss recorded when an asset’s market value drops below its book value.
Shell’s taking an impairment charge of up to $2 billion means acknowledging that the value of its assets—specifically, the Singapore refinery and the halted biofuel plant construction—has decreased significantly.
The British energy company had earlier announced that it would stop construction at its Rotterdam-based biofuel plant in the Netherlands due to weak market conditions.
The biofuels plant was expected to have an annual capacity of 820,000 metric tons and begin operations next year.
Additionally, Shell said the decision will result in a non-cash, post-tax impairment of between $600 million and $1 billion when it publishes its second-quarter results on Aug. 1.
Shell expects an additional write-down of $600 million to $800 million related to its Singapore chemicals and products facility, which it has agreed to sell to a joint venture between commodity trader Glencore Plc and Indonesia’s PT Chandra Asri Pacific.
Read more: Shell set to build two carbon capture hubs in Canada
The company’s gas trading results are expected to be lower in the second quarter (compared to Q1’24) due to seasonal changes in the market.
However, these results will still be similar to the performance of the division during the same period last year (Q2’23).